VHOSPITAL.CLINIC · Referencia de farmacos
Resumen clinico para navegacion en espanol.
Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis in the liver. By reducing LDL cholesterol, they substantially reduce cardiovascular risk.
First-line treatment for hypercholesterolaemia and primary/secondary prevention of cardiovascular disease including heart attack and stroke.
Muscle symptoms are the most common concern — report unexplained muscle pain, weakness, or tenderness. Liver function monitoring is recommended in some guidelines.
Simvastatin
Simvastatin is a statin (HMG-CoA reductase inhibitor) that reduces LDL cholesterol and lowers the risk of cardiovascular events.
Rosuvastatin
Rosuvastatin is a statin (HMG-CoA reductase inhibitor) that reduces LDL cholesterol and lowers the risk of cardiovascular events.
Pravastatin
Pravastatin is a statin (HMG-CoA reductase inhibitor) that reduces LDL cholesterol and lowers the risk of cardiovascular events.
Fluvastatin
Fluvastatin is a statin (HMG-CoA reductase inhibitor) that reduces LDL cholesterol and lowers the risk of cardiovascular events.
Describe tus sintomas y contexto clinico para obtener una evaluacion estructurada con posibles causas y senales de alerta.
Iniciar analisis AI gratis →Aviso medico: Esta referencia farmacologica es informativa y no reemplaza la consulta medica profesional. Antes de iniciar, suspender o cambiar un medicamento, consulta con un profesional sanitario.